| is a: | FF:0000421 (human Lymphatic Endothelial cells 4h after VEGFC treatment sample),FF:0000437 (human MCF7 breast cancer cell line 4h after EGF1 treatment sample),FF:0000453 (human MCF7 breast cancer cell line 4h after HRG treatment sample),FF:0000509 (mouse J2E erythroblastic leukemia line 4hr after treatment with erythropoietin sample),FF:0000525 (human K562 erythroblastic leukemia line 4hr after treatment with hemin sample),FF:0000553 (human Aortic Smooth Muscle cells 4hr after treatment with FGF2 sample),FF:0000563 (human Aortic Smooth Muscle cells 4hr after treatment with IL1b sample),FF:0000577 (human Monocyte-derived macrophages 4h after LPS treatment sample),FF:0000603 (human Saos2 osteosarcoma cell line 4h after induction of calcification with ascorbate and BPG sample),FF:0000614 (mouse EBF KO HPCs induced to T cell 4h sample),FF:0000721 (Saos2 osteosarcoma cell line 4h untreated control),FF:0011233 (mouse tracheal ciliated cells differentiation after 4hr sample),FF:3568-170I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3578-170A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3588-170B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3598-170C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb),FF:3640-171I1 (macrophage, TB infection, stimulated BMDM+IFNg(caMph)),FF:3650-171A3 (macrophage, TB infection, stimulated BMDM+IL-13(aaMph), without Mtb),FF:3660-171B4 (macrophage, TB infection, stimulated BMDM+IL-4/IL-13(aaMph), without Mtb),FF:3670-171C5 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb, 004hr, biol_rep2),FF:3705-172B1 (macrophage, TB infection, non-stimulated BMDM, without Mtb),FF:3971-173H4 (macrophage, TB infection, stimulated BMDM+IL-4(aaMph), without Mtb) |
|---|
